CAREVIEW COMMUNS (CRVW) Financials

CRVW OTC

Trailing 12 months to June 30, 2026

Revenue $9.4M +8.5% YoY

Net Income -$2.7M n/m YoY

Free Cash Flow $166K n/m YoY

Operating Cash Flow $201K n/m YoY

Market Cap $18.3M as of Oct 26, 2026

Price / Sales 1.9x on $9.4M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 12, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CRVW SEC filings page.

CAREVIEW COMMUNS INC (CRVW) reported $9.4M in revenue over the twelve months to Jun 30, 2026, up 8.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CRVW FY2025 2026-10-24

The business improved operating efficiency in FY2025, but remains financed by liabilities far exceeding its asset base.

FY2025 revenue increased 9.3% while SG&A decreased 14.6%, so the rebound was accompanied by a leaner administrative cost base. Operating margin improved 18.5 pp, indicating that cost structure—not revenue alone—drove the operating improvement.

FY2025 operating cash flow was $805K, and free cash flow was $797K, meaning almost all operating cash remained after capital spending. That cash result contrasts with a net loss of $3.2M: reported earnings and cash generation moved in different directions.

Liabilities of $47.7M exceeded assets of $4.6M in FY2025, so the balance sheet relies far more on obligations than owned resources. The 0.1x current ratio shows current assets were only a small fraction of current liabilities, making short-term liquidity the clearest financial constraint in the reported structure.

Financial Health Signals

Financial health score not available

CAREVIEW COMMUNS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-74.21

CAREVIEW COMMUNS INC scores -74.21, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $215.8M against total assets of $4.6M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/7

CAREVIEW COMMUNS INC passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality Mixed

N/A

CAREVIEW COMMUNS INC reported a net loss of $3.2M while generating $805K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

CAREVIEW COMMUNS INC reported an operating loss of $55K against $3.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.8M

YoY+19.6%

QoQ+29.9%

5Y CAGR+13.0%

10Y CAGR+6.4%

CAREVIEW COMMUNS INC generated $2.8M in revenue in Q2 2026. This represents an increase of 19.6% from the same quarter a year earlier. Against the prior quarter it is up 29.9%.

EBITDA

$543K

YoY+125.1%

QoQ+664.1%

5Y CAGRn/m

10Y CAGRn/m

CAREVIEW COMMUNS INC's EBITDA was $543K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 125.1% from the same quarter a year earlier. Against the prior quarter it is up 664.1%.

Net Income

-$284K

YoYn/m

QoQn/m

CAREVIEW COMMUNS INC reported a net loss of $284K in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$508K

YoY-31.0%

QoQn/m

CAREVIEW COMMUNS INC generated $508K in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 31.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$1.9M

YoY+8.9%

QoQ+36.0%

CAREVIEW COMMUNS INC held $1.9M in cash as of Q2 2026; no long-term debt figure is on record for that period.

Shares Outstanding

584M

YoY0.0%

QoQ0.0%

CAREVIEW COMMUNS INC had 584M shares outstanding in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Operating Margin

17.8%

YoY+9.5pp

QoQ+16.4pp

5Y change+65.0pp

10Y change+112.1pp

CAREVIEW COMMUNS INC's operating margin was 17.8% in Q2 2026, reflecting core business profitability. This is up 9.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 16.4 percentage points.

Net Margin

-10.0%

YoY+14.8pp

QoQ+24.5pp

CAREVIEW COMMUNS INC's net profit margin was -10.0% in Q2 2026, showing the share of revenue converted to profit. This is up 14.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 24.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

R&D Spending

$630K

YoY+15.1%

QoQ+1.4%

5Y CAGR+9.4%

10Y CAGR+6.7%

CAREVIEW COMMUNS INC invested $630K in research and development in Q2 2026. This represents an increase of 15.1% from the same quarter a year earlier. Against the prior quarter it is up 1.4%.

Capital Expenditures

$21K

YoY+549.5%

QoQ+131.3%

CAREVIEW COMMUNS INC invested $21K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 549.5% from the same quarter a year earlier. Against the prior quarter it is up 131.3%.

Share Buybacks

Not reported for Q2 2026.

CRVW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRVW quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$9.4M	$9.0M+9.3%	$8.3M-14.8%	$9.7M+22.6%	$7.9M+1.3%	$7.8M+20.3%	$6.5M+3.1%	$6.3M+3.2%	$6.1M-2.7%	$6.3M+4.9%	$6.0M+16.2%	$5.1M+67.9%	$3.1M+48.0%	$2.1M+26.9%	$1.6M+158.5%	$630K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$28K-6.7%	$30K-70.9%	$103K+4.0%	$99K	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	$6.5M+3.1%	$6.3M+4.5%	$6.0M-2.8%	$6.2M	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$2.5M	$2.4M+2.6%	$2.4M-6.0%	$2.5M+27.2%	$2.0M+15.0%	$1.7M+0.2%	$1.7M+22.0%	$1.4M-2.0%	$1.4M-13.3%	$1.6M+31.6%	$1.3M+15.4%	$1.1M+28.7%	$843K-2.0%	$860K-9.5%	$951K+15.7%	$822K
SG&A Expenses	$3.2M	$3.3M-14.6%	$3.9M-9.0%	$4.3M+9.8%	$3.9M+3.1%	$3.8M+14.5%	$3.3M-24.7%	$4.4M+20.7%	$3.6M-22.9%	$4.7M+3.7%	$4.5M-1.2%	$4.6M+15.9%	$4.0M-1.9%	$4.0M-40.1%	$6.7M+31.8%	$5.1M
Operating Income	$419K	-$55Kn/m	-$1.6Mn/m	-$688Kn/m	-$1.3Mn/m	-$1.1Mn/m	-$1.9Mn/m	-$3.2Mn/m	-$3.7Mn/m	-$6.6Mn/m	-$6.3Mn/m	-$6.9Mn/m	-$6.8Mn/m	-$6.9Mn/m	-$11.1Mn/m	-$9.0M
EBITDA	N/A	$111Kn/m	-$1.3Mn/m	-$354Kn/m	-$769Kn/m	-$568Kn/m	-$1.3Mn/m	-$2.5Mn/m	-$2.4Mn/m	-$4.7Mn/m	-$4.5Mn/m	-$5.1Mn/m	-$5.1Mn/m	-$5.3Mn/m	-$9.0Mn/m	-$7.4M
Interest Expense	$3.2M	$3.2M0.0%	$3.2M0.0%	$3.2M-48.8%	$6.3M-30.0%	$9.0M-15.5%	$10.6M-2.4%	$10.9M-12.9%	$12.5M-7.6%	$13.5M+7.0%	$12.6M+30.5%	$9.7M+23.4%	$7.8M+10.6%	$7.1M-7.8%	$7.7M+72.6%	$4.4M
Income Tax	$6K	$6Kn/m	-$29K-139.5%	$75K	N/A	N/A	N/A	$0n/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$2.7M	-$3.2Mn/m	-$4.7Mn/m	-$4.0M	N/A	N/A	N/A	N/A	N/A	-$20.1Mn/m	-$18.6Mn/m	-$16.4Mn/m	-$14.5Mn/m	-$13.7Mn/m	-$18.6Mn/m	-$16.4M
EPS (Basic)	N/A	-$0.01n/m	-$0.01n/m	-$0.01	-$0.04	-$0.07n/m	-$0.08n/m	-$0.10n/m	-$0.12n/m	-$0.14n/m	-$0.13n/m	-$0.12n/m	-$0.10n/m	-$0.10n/m	-$0.14n/m	-$0.13
EPS (Diluted)	—	N/A	N/A	-$0.01	-$0.04	-$0.07n/m	-$0.08n/m	-$0.10n/m	-$0.12n/m	-$0.14n/m	-$0.13n/m	-$0.12n/m	-$0.10n/m	-$0.10n/m	-$0.14n/m	-$0.13
Diluted Shares (Avg)	N/A	N/A	N/A	448M	142M	139M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$2.8M+19.6%	$2.2M-2.1%	$2.3M+8.9%	$2.1M+6.8%	$2.4M+20.5%	$2.2M+1.6%	$2.1M+21.2%	$1.9M-20.3%
R&D Expenses	$630K+15.1%	$621K+6.9%	$676K-5.5%	$610K+2.8%	$547K+6.2%	$580K+10.0%	$716K-15.5%	$594K-4.5%
SG&A Expenses	$766K-4.7%	$768K-10.5%	$793K-8.4%	$865K-17.7%	$804K-21.6%	$858K-9.2%	$865K-14.9%	$1.1M-5.2%
Operating Income	$507K+155.1%	$31Kn/m	$13Kn/m	-$132Kn/m	$199Kn/m	-$135Kn/m	-$340Kn/m	-$684Kn/m
EBITDA	$543K+125.1%	$71Kn/m	$49Kn/m	-$97Kn/m	$241Kn/m	-$82Kn/m	-$296Kn/m	-$618K-1279.8%
Interest Expense	$802K0.0%	$802K0.0%	$802K0.0%	$802K0.0%	$802K0.0%	$802K0.0%	$802K+17.9%	$802K-3.5%
Income Tax	$0n/m	$0n/m	$6Kn/m	$0n/m	$0n/m	$0n/m	-$29K	$0n/m
Net Income	-$284Kn/m	-$756Kn/m	-$777Kn/m	-$914Kn/m	-$589Kn/m	-$921Kn/m	-$1.1Mn/m	-$1.5Mn/m
EPS (Basic)	$0.00n/m	$0.00n/m	-$0.01n/m	$0.00n/m	$0.00n/m	$0.00n/m	$0.00n/m	$0.00n/m

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, EPS (Diluted), Diluted Shares (Avg).

CRVW Balance Sheet

CRVW quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$4.6M+28.1%	$3.6M-15.0%	$4.3M+8.0%	$3.9M-22.3%	$5.1M-7.7%	$5.5M+4.0%	$5.3M-35.3%	$8.2M-32.5%	$12.1M-43.5%	$21.5M-28.8%	$30.1M+203.1%	$9.9M-20.1%	$12.4M-22.6%	$16.1M-26.8%	$22.0M
Current Assets	$3.2M+20.6%	$2.7M-9.5%	$2.9M+59.9%	$1.8M-15.4%	$2.2M+0.9%	$2.2M0.0%	$2.2M-44.5%	$3.9M+0.6%	$3.9M-65.7%	$11.3M-41.7%	$19.3M+451.7%	$3.5M-23.8%	$4.6M-23.1%	$6.0M-34.1%	$9.1M
Cash & Equivalents	$1.5M+103.7%	$759K-33.7%	$1.1M+172.7%	$420K-36.3%	$659K+84.2%	$358K+32.7%	$270K-77.5%	$1.2M-73.7%	$4.6M-63.7%	$12.6M-28.8%	$17.7M+594.3%	$2.5M-38.3%	$4.1M-23.8%	$5.4M-36.5%	$8.5M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$403K-3.7%	$418K+42.0%	$294K-2.3%	$301K-13.7%	$349K-14.5%	$408K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$1.0M+2.7%	$1.0M-14.3%	$1.2M+23.2%	$948K+1.6%	$933K-18.6%	$1.1M-31.2%	$1.7M+30.5%	$1.3M+5.5%	$1.2M+13.2%	$1.1M-9.1%	$1.2M+73.0%	$680K+123.0%	$305K-17.1%	$368K+96.8%	$187K
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Total Liabilities	$47.7M+8.2%	$44.1M+8.7%	$40.5M-49.7%	$80.6M-31.6%	$117.8M+8.3%	$108.8M+12.1%	$97.0M+12.8%	$86.0M+15.8%	$74.3M+15.8%	$64.2M+14.9%	$55.9M+121.2%	$25.2M+36.2%	$18.5M+29.5%	$14.3M+137.2%	$6.0M
Current Liabilities	$46.7M+6.6%	$43.8M+8.9%	$40.2M-39.2%	$66.1M-26.0%	$89.3M+20.4%	$74.2M+189.8%	$25.6M+46.8%	$17.4M+80.7%	$9.6M+410.9%	$1.9M-3.4%	$2.0M+59.3%	$1.2M-40.5%	$2.1M+11.5%	$1.8M+13.2%	$1.6M
Non-Current Liabilities	$962K+277.7%	$255K-19.9%	$318K-97.8%	$14.5M-48.9%	$28.4M-17.7%	$34.6M-51.6%	$71.4M+4.2%	$68.6M+6.1%	$64.6M+3.8%	$62.3M+15.5%	$53.9M+124.4%	$24.0M+45.8%	$16.5M+32.1%	$12.5M+183.2%	$4.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$52.4M+24.0%	$42.3M+25.3%	$33.7M+47.7%	$22.8M+50.2%	$15.2M	N/A	$3.9M
Total Equity	-$43.0Mn/m	-$40.4Mn/m	-$36.3Mn/m	-$76.7Mn/m	-$112.7Mn/m	-$103.3Mn/m	-$91.7Mn/m	-$77.8Mn/m	-$62.2Mn/m	-$42.7Mn/m	-$25.7Mn/m	-$15.3Mn/m	-$6.1M-269.9%	$3.6M-77.5%	$15.9M
Retained Earnings	-$215.8Mn/m	-$212.6Mn/m	-$207.9Mn/m	-$203.9Mn/m	-$197.9Mn/m	-$187.8Mn/m	-$176.1Mn/m	-$162.0Mn/m	-$145.9Mn/m	-$126.4Mn/m	-$107.8Mn/m	-$91.5Mn/m	-$77.1Mn/m	-$65.3Mn/m	-$46.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$5.9M+6.7%	$4.8M+22.4%	$4.6M+28.1%	$5.0M+20.0%	$5.5M+9.6%	$3.9M	$3.6M-15.0%	$4.1M-13.2%
Current Assets	$4.5M+13.7%	$3.4M+11.8%	$3.2M+20.6%	$3.5M+14.2%	$4.0M+4.2%	$3.1M	$2.7M-9.5%	$3.1M+0.7%
Cash & Equivalents	$1.9M+8.9%	$1.4M+37.6%	$1.5M+103.7%	$1.7M+23.6%	$1.8M+1.4%	$1.0M	$759K-33.7%	$1.4M+107.8%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0	$0n/m	$0n/m
Inventory	$543K+49.0%	$523K+36.4%	$403K-3.7%	$426K+34.1%	$364K+17.8%	$383K	$418K+42.0%	$317K+36.4%
Accounts Receivable	$1.7M+15.3%	$1.3M-7.8%	$1.0M+2.7%	$1.0M+5.2%	$1.5M+12.8%	$1.4M	$1.0M-14.3%	$997K-45.4%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0	$0n/m	$0n/m
Total Liabilities	$49.6M+5.3%	$48.4M+7.3%	$47.7M+8.2%	$47.4M+8.5%	$47.2M+9.1%	$45.1M	$44.1M+8.7%	$43.6M+10.9%
Current Liabilities	$48.8M+5.8%	$47.5M+6.1%	$46.7M+6.6%	$46.3M+6.8%	$46.2M+7.0%	$44.7M	$43.8M+8.9%	$43.4M+11.1%
Non-Current Liabilities	$822K-17.8%	$942K+152.6%	$962K+277.7%	$1.1M+269.0%	$1.0M+909.3%	$373K	$255K-19.9%	$287K-14.1%
Total Equity	-$43.8Mn/m	-$43.6Mn/m	-$43.0Mn/m	-$42.4Mn/m	-$41.6Mn/m	-$41.2Mn/m	-$40.4Mn/m	-$39.5Mn/m
Retained Earnings	-$216.8Mn/m	-$216.5Mn/m	-$215.8Mn/m	-$215.0Mn/m	-$214.1Mn/m	-$213.5M	-$212.6Mn/m	-$211.5Mn/m

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

CRVW Cash Flow Statement

CRVW quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$201K	$805Kn/m	-$305K-143.4%	$704Kn/m	-$370K-154.5%	$679Kn/m	-$791Kn/m	-$1.4Mn/m	-$4.8Mn/m	-$6.3Mn/m	-$6.1Mn/m	-$5.3Mn/m	-$4.5Mn/m	-$4.6Mn/m	-$7.3Mn/m	-$5.7M
Depreciation & Amortization	N/A	$166K-33.9%	$251K-25.1%	$335K-33.3%	$502K-13.3%	$579K+9.0%	$531K-26.3%	$721K-43.9%	$1.3M-31.9%	$1.9M+3.9%	$1.8M+5.1%	$1.7M+4.6%	$1.7M+2.5%	$1.6M-23.7%	$2.1M+35.8%	$1.6M
Stock-Based Compensation	N/A	N/A	N/A	$150K-34.7%	$230K+3.2%	$223K+42.6%	$156K-1.6%	$159K-39.6%	$263K-33.9%	$398K-44.5%	$717K-7.4%	$774K+8.4%	$714K+82.9%	$390K-51.9%	$812K	N/A
Capital Expenditures	$35K	$9K-81.2%	$46K+174.5%	$17K+223.6%	$5K-94.8%	$99K-30.4%	$143K-9.7%	$158K-63.5%	$432K-56.5%	$995K-30.5%	$1.4M+62.8%	$879K+46.0%	$602K+468.1%	$106K-80.3%	$538K-90.9%	$5.9M
Free Cash Flow	$166K	$797Kn/m	-$351K-151.1%	$687Kn/m	-$375K-164.8%	$580Kn/m	-$934Kn/m	-$1.6Mn/m	-$5.3Mn/m	-$7.3Mn/m	-$7.5Mn/m	-$6.2Mn/m	-$5.1Mn/m	-$4.7Mn/m	-$7.9Mn/m	-$11.7M
Investing Cash Flow	-$44K	-$18Kn/m	-$74Kn/m	-$62Kn/m	-$5Kn/m	-$227Kn/m	-$302Kn/m	-$344Kn/m	-$624Kn/m	-$1.3Mn/m	-$1.5M	N/A	-$1.0Mn/m	-$444Kn/m	-$1.0Mn/m	-$6.8M
Financing Cash Flow	N/A	$0n/m	-$8Kn/m	-$15K-106.5%	$236Kn/m	-$150K-112.7%	$1.2M+1081.8%	$100K-96.5%	$2.9Mn/m	-$500Kn/m	-$5K	N/A	$4.0M+7.2%	$3.7M-29.0%	$5.2M-75.2%	$21.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$530K-28.4%	-$126K-147.1%	-$228Kn/m	$26Kn/m	$740K+19.4%	$268K+106.8%	-$698K-231.0%	-$356Kn/m
Depreciation & Amortization	$36K-15.2%	$40K-23.6%	$36K-19.8%	$35K-47.6%	$42K-37.8%	$53K-26.0%	$44K+36.5%	$67K-30.2%
Stock-Based Compensation	N/A	$150K-2.9%	N/A	$156K-2.0%	$156K-1.5%	$155K+190.5%	N/A	$159K+539.0%
Capital Expenditures	$21K+549.5%	$9K+757.9%	$4K-60.1%	$478-92.9%	$3K-84.0%	$1K-88.3%	$10K-8.2%	$7K+49.2%
Free Cash Flow	$508K-31.0%	-$135K-150.8%	-$232Kn/m	$25Kn/m	$737K+22.9%	$267K+121.8%	-$707K-235.5%	-$363Kn/m
Investing Cash Flow	-$21Kn/m	-$9Kn/m	$44K-23.2%	-$57K-385.4%	-$3Kn/m	-$1Kn/m	$57Kn/m	$20Kn/m
Financing Cash Flow	N/A	N/A	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	-$2Kn/m

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CRVW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CRVW quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	99.6%+0.1pp	99.5%+1.2pp	98.3%-0.1pp	98.4%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-0.6%+18.5pp	-19.1%-12.0pp	-7.1%+9.0pp	-16.1%-1.4pp	-14.7%+14.2pp	-28.9%+22.5pp	-51.4%+8.4pp	-59.9%	-105.6%	-105.6%	-133.5%	-221.5%	-334.3%	-679.4%	-1422.4%
Net Margin	-35.5%+21.5pp	-57.0%-16.2pp	-40.8%	N/A	N/A	N/A	N/A	N/A	-320.4%	-311.6%	-318.1%	-474.0%	-660.7%	-1141.5%	-2597.4%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-518.6%-415.8pp	-102.9%
Return on Assets	-69.0%+60.8pp	-129.8%-37.1pp	-92.7%	N/A	N/A	N/A	N/A	N/A	-165.6%-78.9pp	-86.8%-32.5pp	-54.3%+91.7pp	-145.9%-36.1pp	-109.9%+5.9pp	-115.8%-41.2pp	-74.6%
Current Ratio	0.070.0x	0.060.0x	0.070.0x	0.030.0x	0.020.0x	0.03-0.1x	0.08-0.1x	0.22-0.2x	0.40-5.6x	5.97-3.9x	9.88+7.0x	2.85+0.6x	2.23-1.0x	3.23-2.3x	5.55
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.24
Liabilities-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	3.99+3.6x	0.38
Asset Turnover	1.94-0.3x	2.280.0x	2.27+0.3x	2.00+0.5x	1.54+0.4x	1.180.0x	1.19+0.4x	0.75+0.2x	0.52+0.2x	0.28+0.1x	0.17-0.1x	0.31+0.1x	0.17+0.1x	0.10+0.1x	0.03
FCF Margin	8.8%+13.1pp	-4.3%-11.3pp	7.1%+11.8pp	-4.8%-12.2pp	7.4%+21.8pp	-14.4%+10.9pp	-25.3%+61.2pp	-86.5%	-115.8%	-125.6%	-121.0%	-168.0%	-225.2%	-482.3%	-1851.8%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	17.8%+9.5pp	1.4%+7.4pp	0.6%+16.4pp	-6.4%+29.0pp	8.4%+24.5pp	-6.0%+4.6pp	-15.9%+37.8pp	-35.4%-33.6pp
Net Margin	-10.0%+14.8pp	-34.5%+6.6pp	-33.3%+18.1pp	-44.3%+31.8pp	-24.8%+31.4pp	-41.1%+5.3pp	-51.4%+44.3pp	-76.1%-40.2pp
Return on Assets	-4.8%+5.9pp	-15.8%+7.8pp	-16.7%+13.7pp	-18.4%+17.1pp	-10.7%+11.3pp	-23.5%	-30.4%+9.3pp	-35.5%-17.3pp
Current Ratio	0.090.0x	0.070.0x	0.070.0x	0.080.0x	0.090.0x	0.07	0.060.0x	0.070.0x
Asset Turnover	0.48+0.1x	0.46-0.1x	0.50-0.1x	0.41-0.1x	0.430.0x	0.57	0.59+0.2x	0.470.0x
FCF Margin	17.9%-13.1pp	-6.2%-18.1pp	-9.9%+23.1pp	1.2%+20.0pp	31.0%+0.6pp	11.9%+6.5pp	-33.0%-62.6pp	-18.8%-17.6pp

Not reported in any period shown, so not listed: Gross Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity.

Note: Shareholder equity is negative (-$43.0M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Where CAREVIEW COMMUNS INC Ranks

Frequently Asked Questions

What is CAREVIEW COMMUNS INC's annual revenue?

CAREVIEW COMMUNS INC (CRVW) reported $9.0M in total revenue for fiscal year 2025. This represents a 9.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CAREVIEW COMMUNS INC's revenue growing?

CAREVIEW COMMUNS INC (CRVW) revenue grew by 9.3% year-over-year, from $8.3M to $9.0M in fiscal year 2025.

Is CAREVIEW COMMUNS INC profitable?

No, CAREVIEW COMMUNS INC (CRVW) reported a net loss of $2.7M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $3.2M, with a net profit margin of -35.5%.

What is CAREVIEW COMMUNS INC's EBITDA?

CAREVIEW COMMUNS INC (CRVW) had EBITDA of $111K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is CAREVIEW COMMUNS INC's operating margin?

CAREVIEW COMMUNS INC (CRVW) had an operating margin of -0.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CAREVIEW COMMUNS INC's net profit margin?

CAREVIEW COMMUNS INC (CRVW) had a net profit margin of -35.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CAREVIEW COMMUNS INC's free cash flow?

CAREVIEW COMMUNS INC (CRVW) generated $797K in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CAREVIEW COMMUNS INC's operating cash flow?

CAREVIEW COMMUNS INC (CRVW) generated $805K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CAREVIEW COMMUNS INC's total assets?

CAREVIEW COMMUNS INC (CRVW) had $4.6M in total assets as of fiscal year 2025, including both current and long-term assets.

What are CAREVIEW COMMUNS INC's capital expenditures?

CAREVIEW COMMUNS INC (CRVW) invested $9K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does CAREVIEW COMMUNS INC spend on research and development?

CAREVIEW COMMUNS INC (CRVW) invested $2.4M in research and development during fiscal year 2025.

How many shares does CAREVIEW COMMUNS INC have outstanding?

CAREVIEW COMMUNS INC (CRVW) had 584M shares outstanding as of fiscal year 2025.

What is CAREVIEW COMMUNS INC's current ratio?

CAREVIEW COMMUNS INC (CRVW) had a current ratio of 0.07 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is CAREVIEW COMMUNS INC's return on assets (ROA)?

CAREVIEW COMMUNS INC (CRVW) had a return on assets of -69.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CAREVIEW COMMUNS INC's P/E ratio?

CAREVIEW COMMUNS INC (CRVW) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $18.3M as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is CAREVIEW COMMUNS INC's price-to-sales ratio?

CAREVIEW COMMUNS INC (CRVW) trades at 1.9x sales, its market capitalization divided by $9.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $18.3M as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Why is CAREVIEW COMMUNS INC's debt-to-equity ratio negative or not reported?

CAREVIEW COMMUNS INC (CRVW) has negative shareholder equity of -$43.0M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is CAREVIEW COMMUNS INC's Altman Z-Score?

CAREVIEW COMMUNS INC (CRVW) has an Altman Z-Score of -74.21, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is CAREVIEW COMMUNS INC's Piotroski F-Score?

CAREVIEW COMMUNS INC (CRVW) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CAREVIEW COMMUNS INC's earnings high quality?

CAREVIEW COMMUNS INC (CRVW) reported a net loss of $3.2M while generating $805K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CAREVIEW COMMUNS INC cover its interest payments?

CAREVIEW COMMUNS INC (CRVW) reported an operating loss of $55K against $3.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.